HER2 plays a pivotal role in tumor cell proliferation and metastasis, is found to be implicated in various cancer-poor prognoses, and is associated with aggressive and lethal forms of cancer, including ovarian cancer (Luo et al., 2018; Galogre et al., 2023). Here, ERBB2 is linked to ovarian carcinoma.